Scott G Weiner1, Laura C Horton2, Traci C Green3, Stephen F Butler4. 1. Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, United States. Electronic address: sweiner@bwh.harvard.edu. 2. Tufts University School of Medicine, Boston, MA, United States. Electronic address: laura.horton@tufts.edu. 3. Boston Medical Center and Boston University Department of Emergency Medicine Providence, RI Inflexxion, Inc., Newton, MA, United States. Electronic address: traci.c.green@gmail.com. 4. Inflexxion, Inc., Newton, MA, United States. Electronic address: sfbutler@inflexxion.com.
Abstract
OBJECTIVES: This study aimed to: (a) determine the percentage of ED patients receiving prescriptions for opioid pain medications that meet the criteria for "high-risk for abuse potential" on the Screener and Opioid Assessment for Patients with Pain (SOAPP(®)-R), (b) determine the percentage of patients with high-risk behavior on the state prescription drug monitoring program (PDMP) database, (c) compare the SOAPP-R with data from the PDMP, and (d) determine psychometric properties of SOAPP-R for ED patients METHODS: Convenience sample of ED patients who were being considered for discharge with a prescription for an opioid pain medication. Subjects completed SOAPP-R on an electronic tablet and PDMP data was obtained. Scores on SOAPP-R ≥ 18 were defined as "at-risk", and PDMP data showing both ≥ 4 opioid prescriptions and ≥ 4 providers in 12 months was considered the criterion standard for high-risk behavior. RESULTS: 82 patients (88.2%) provided consent. 32.9% (n=27) were determined to be "at-risk" (score ≥ 18) by SOAPP-R. 15.9% (n=13) subjects met PDMP criteria and 53.9% (n=7) of those had SOAPP-R scores ≥ 18 (sensitivity 54%, specificity 71%, positive predictive value 26%, negative predictive value 89%). The association of an at-risk SOAPP-R score and PDMP high-risk criteria was an adjusted odds ratio of 1.39 (95% confidence interval 0.73-3.68). CONCLUSIONS: In our population, about one-third of patients being considered for discharge with an opioid prescription scored "at-risk" on SOAPP-R and 15.9% met the PDMP high-risk criteria. The high negative predictive value of SOAPP-R indicates it may be a useful screening tool for the ED patient population.
OBJECTIVES: This study aimed to: (a) determine the percentage of ED patients receiving prescriptions for opioid pain medications that meet the criteria for "high-risk for abuse potential" on the Screener and Opioid Assessment for Patients with Pain (SOAPP(®)-R), (b) determine the percentage of patients with high-risk behavior on the state prescription drug monitoring program (PDMP) database, (c) compare the SOAPP-R with data from the PDMP, and (d) determine psychometric properties of SOAPP-R for ED patients METHODS: Convenience sample of ED patients who were being considered for discharge with a prescription for an opioid pain medication. Subjects completed SOAPP-R on an electronic tablet and PDMP data was obtained. Scores on SOAPP-R ≥ 18 were defined as "at-risk", and PDMP data showing both ≥ 4 opioid prescriptions and ≥ 4 providers in 12 months was considered the criterion standard for high-risk behavior. RESULTS: 82 patients (88.2%) provided consent. 32.9% (n=27) were determined to be "at-risk" (score ≥ 18) by SOAPP-R. 15.9% (n=13) subjects met PDMP criteria and 53.9% (n=7) of those had SOAPP-R scores ≥ 18 (sensitivity 54%, specificity 71%, positive predictive value 26%, negative predictive value 89%). The association of an at-risk SOAPP-R score and PDMP high-risk criteria was an adjusted odds ratio of 1.39 (95% confidence interval 0.73-3.68). CONCLUSIONS: In our population, about one-third of patients being considered for discharge with an opioid prescription scored "at-risk" on SOAPP-R and 15.9% met the PDMP high-risk criteria. The high negative predictive value of SOAPP-R indicates it may be a useful screening tool for the ED patient population.
Authors: Herbert C Duber; Isabel A Barata; Eric Cioè-Peña; Stephen Y Liang; Eric Ketcham; Wendy Macias-Konstantopoulos; Shawn A Ryan; Mark Stavros; Lauren K Whiteside Journal: Ann Emerg Med Date: 2018-06-05 Impact factor: 5.721
Authors: Shawn M Varney; Crystal A Perez; Allyson A Araña; Katherine R Carey; Victoria J Ganem; Lee A Zarzabal; Rosemarie G Ramos; Vikhyat S Bebarta Journal: Intern Emerg Med Date: 2018-03-03 Impact factor: 3.397
Authors: Matthew D Finkelman; Ronald J Kulich; Stephen F Butler; William C Jackson; Franklin D Friedman; Niels Smits; Scott G Weiner Journal: J Pain Res Date: 2016-12-05 Impact factor: 3.133
Authors: Rosa Esteve; Ángela Reyes-Pérez; Carmen Ramírez-Maestre; Andrea Gutiérrez-Extremera; Rocío Fuentes-Bravo; Rocío de la Vega; Gema T Ruíz-Párraga; Elena R Serrano-Ibáñez; Alicia E López-Martínez Journal: Pain Ther Date: 2022-02-07
Authors: Lauren K Whiteside; Jason Goldstick; Aaron Dora-Laskey; Laura Thomas; Maureen Walton; Rebecca Cunningham; Amy S B Bohnert Journal: West J Emerg Med Date: 2018-06-11
Authors: Bertram K Woitok; Petra Büttiker; Svenja Ravioli; Georg-Christian Funk; Aristomenis K Exadaktylos; Gregor Lindner Journal: BMJ Open Date: 2020-09-25 Impact factor: 2.692